Impressive Earnings May Not Tell The Whole Story For Orion Oyj (HEL:ORNBV)
Nov 06
Have your own idea? Try our Stock Screener
Finnish (OMX) Pharma Industry Analysis
UpdatedNov 18, 2024
DataAggregated Company Financials
Companies2
- 7D-1.1%
- 3M-4.5%
- 1Y18.2%
- YTD11.5%
Over the last 7 days, the Pharma industry has dropped 1.1%, driven by pullbacks from every company within the industry. This takes the industry's 12 month performance to a gain of 18%. As for the next few years, earnings are expected to grow by 9.3% per annum.
Industry Valuation and Performance
Has the Finnish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 19 Nov 2024 | €6.3b | €1.4b | €331.1m | 18.9x | 19x | 4.4x |
| Thu, 17 Oct 2024 | €6.7b | €1.3b | €231.7m | 28.8x | 28.9x | 5.3x |
| Sat, 14 Sep 2024 | €6.5b | €1.3b | €231.7m | 28.1x | 28.2x | 5.2x |
| Mon, 12 Aug 2024 | €6.2b | €1.3b | €232.6m | 64.7x | 26.7x | 4.9x |
| Wed, 10 Jul 2024 | €5.8b | €1.2b | €217.1m | 67.3x | 26.5x | 4.7x |
| Fri, 07 Jun 2024 | €5.5b | €1.2b | €217.1m | 71.3x | 25.3x | 4.5x |
| Sun, 05 May 2024 | €5.1b | €1.2b | €217.1m | 62.7x | 23.5x | 4.2x |
| Tue, 02 Apr 2024 | €4.9b | €1.2b | €217.1m | 61.8x | 22.5x | 4.1x |
| Thu, 29 Feb 2024 | €5.2b | €1.2b | €216.8m | 24x | 23.9x | 4.4x |
| Sat, 27 Jan 2024 | €6.1b | €1.2b | €173.2m | 35.4x | 35.4x | 5.3x |
| Mon, 25 Dec 2023 | €5.5b | €1.2b | €173.2m | 31.8x | 31.8x | 4.7x |
| Wed, 22 Nov 2023 | €5.3b | €1.2b | €173.2m | 30.3x | 30.4x | 4.5x |
| Fri, 20 Oct 2023 | €5.1b | €1.4b | €306.3m | 16.8x | 16.8x | 3.8x |
| Sun, 17 Sep 2023 | €5.2b | €1.4b | €306.3m | 16.8x | 16.8x | 3.8x |
| Tue, 15 Aug 2023 | €4.9b | €1.4b | €306.3m | 16.1x | 16.1x | 3.6x |
| Thu, 13 Jul 2023 | €5.2b | €1.3b | €336.0m | 15.4x | 15.4x | 3.8x |
| Sat, 10 Jun 2023 | €5.7b | €1.3b | €336.0m | 16.7x | 17.1x | 4.3x |
| Mon, 08 May 2023 | €6.1b | €1.3b | €336.0m | 18x | 18x | 4.5x |
| Wed, 05 Apr 2023 | €6.0b | €1.3b | €349.5m | 17x | 17.1x | 4.4x |
| Fri, 03 Mar 2023 | €6.3b | €1.3b | €339.0m | 17.9x | 18.6x | 4.7x |
| Sun, 29 Jan 2023 | €6.9b | €1.3b | €340.2m | 19.7x | 20.4x | 5.2x |
| Tue, 27 Dec 2022 | €7.5b | €1.3b | €340.2m | 21.3x | 22x | 5.7x |
| Thu, 24 Nov 2022 | €6.9b | €1.3b | €350.7m | 19.6x | 19.6x | 5.2x |
| Sat, 22 Oct 2022 | €5.9b | €1.3b | €350.7m | 16.9x | 16.8x | 4.5x |
| Mon, 19 Sep 2022 | €6.1b | €1.1b | €201.7m | 30.5x | 30.4x | 5.7x |
| Wed, 17 Aug 2022 | €6.6b | €1.1b | €201.7m | 32.5x | 32.5x | 6.1x |
| Fri, 15 Jul 2022 | €6.9b | €1.0b | €191.5m | 35.8x | 35.8x | 6.6x |
| Sun, 12 Jun 2022 | €5.1b | €1.0b | €191.5m | 26.8x | 26.8x | 4.9x |
| Tue, 10 May 2022 | €4.9b | €1.0b | €191.5m | 25.9x | 25.8x | 4.7x |
| Thu, 07 Apr 2022 | €5.9b | €1.0b | €193.8m | 30.6x | 30.6x | 5.7x |
| Sat, 05 Mar 2022 | €5.6b | €1.0b | €193.8m | 28.8x | 28.7x | 5.4x |
| Mon, 31 Jan 2022 | €5.0b | €1.0b | €186.5m | 27.1x | 27x | 4.9x |
| Wed, 29 Dec 2021 | €5.1b | €1.0b | €186.5m | 27.4x | 27.3x | 5x |
| Fri, 26 Nov 2021 | €5.2b | €1.0b | €186.5m | 27.9x | 27.9x | 5.1x |
Price to Earnings Ratio
27.9x
Current Industry PE
- There are only 2 companies in the Finnish Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 21% per year over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Finnish Healthcare industry?
| FI Market | -0.85% | |
| Healthcare | -1.06% | |
| Pharma | -1.14% | |
| Pharma | -1.14% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||